Advanced Skin Cancers Coverage from Every Angle


ASCO 2023: KEYNOTE-942 Evaluates mRNA-4157 Plus Pembrolizumab in Resected Melanoma
ASCO 2024: Quality of Life With Neoadjuvant Immunotherapy for Stage III Melanoma
ASCO 2024: Use of Tilsotolimod Plus Ipilimumab vs Ipilimumab Alone in Advanced Melanoma
ASCO 2024: Immunotherapy for Ulcer-Related Squamous Cell Skin Cancer
ASCO 2024: BRAF and MEK Inhibitors Plus Immunotherapy for BRAF V600E/K–Mutated Melanoma
ASCO 2024: Intratumoral Daromun Under Study in Resectable Metastatic Melanoma
ASCO 2024: Risk-Adapted Surgical De-escalation for Resectable Squamous Cell Carcinoma
ASCO 2024: Staging and Treating High-Risk Cutaneous Melanoma During Pregnancy
ASCO 2024: Triplet Immunotherapy Regimen Focus of Study in Advanced Melanoma
ASCO 2024: Phase III Trial Evaluates Neoadjuvant Immunotherapy for Stage III Melanoma
Primary and Metastatic Melanomas: Melanocortin-1 Receptor as Potential Therapeutic Target
HPV ctDNA: Potential Biomarker in Monitoring Response to Treatment in Skin Cancer
Anti–PD-1 Response and Noncoding RNAs in Squamous Cell Skin Cancer
Restoring Drug Sensitivity to BRAF and MEK Inhibition in Double-Resistant Melanoma Cells
Merkel Cell Carcinoma: Potentially Modifiable Risk Factors
Use of High-Frequency Ultrasound in Preoperative Assessment of Melanoma
Potential Alternative to SLNB in Melanoma: Integrated 31-Gene-Expression Profile Test
Italian Oncologists Surveyed on Radiotherapy for Non-Melanoma Skin Cancer
Gene-Expression Profiles and Response to Pembrolizumab in Advanced Squamous Cell Skin Cancer
Impact of Comorbidities on Melanoma Risk and Survival
Can Silibinin Consumption Protect Against UVB-Induced Basal Cell Carcinoma?
Evaluating the Risk of Secondary Primary Malignancy in Patients With Melanoma
Location of Non-Melanoma Skin Cancers: Same for Both Men and Women?
NCCN Annual Conference: Managing Basal Cell and Squamous Cell Skin Cancers by Risk Status
AACR 2024: Rural Residency and Melanoma Mortality
NCCN Annual Conference: Update on Managing Cutaneous Melanoma
Relationship Between Somatic Mutations and Risk of Skin Cancer Under Investigation
Trends in Melanoma Surveillance and Their Clinical Implications
Some Antihypertensive Drugs May Increase Susceptibility to Skin Cancer, Study Finds
AACR 2024: Biomarker Offers Clues to Melanoma Resistance to Immune Checkpoint Blockade
AACR 2024: Novel Biomarker and Potential Therapeutic Target Identified in Cutaneous SCC
Detecting and Preventing Skin Cancer for Individuals With Intellectual Disabilities
Anti–PD-L1 Refractory Melanoma: Combining Tyrosine Kinase and PD-1 Inhibitors
Noncoding Genes and Therapeutic Research in Basal Cell Carcinoma
SSO 2024: Do Surgical Characteristics Impact TIL Therapy Outcomes in Melanoma?
AAD 2024: Frankincense Application May Impact Melanoma Diagnosis
Targeting Cutaneous and Rare Melanoma Subtypes With Anti-TYRP1 CAR T-Cell Therapy
AAD 2024: Case Study Opens Debate About Surveillance After Merkel Cell Carcinoma
SSO 2024: Understanding Recurrence of Cutaneous Melanoma During and After Adjuvant Immunotherapy
AAD 2024: Keynote Speaker William Shatner Shares His Journey With Stage IV Melanoma
AAD 2024: ‘Sustained’ Activity Reported With Sonidegib in Locally Advanced Basal Cell Carcinoma
Novel T-Cell Therapy After PD-1 Blockade Under Study in Merkel Cell Carcinoma
AAD 2024: Melanoma Subtype–Specific Outcomes in Black vs White Patients
AAD 2024: Factors Associated With Skin Graft Receipt and Hospital Charges in Basal Cell Carcinoma
Combined-Modality Approach to Treatment of Basal Cell Carcinoma of the Head and Neck
Advanced Non-Melanoma Skin Cancer: Avoiding Surgery With Upfront Systemic and Radiation Therapies
BRAF V600–Mutated Melanoma: Long-Term Outcomes With Immunotherapy
Cannabis Extract PHEC-66: Potential Adjuvant Therapy for Malignant Melanoma?
Merkel Cell Carcinoma: Timing of Surgery and Survival Outcomes
FDA Grants Accelerated Approval to Cellular Therapy for Unresectable or Metastatic Melanoma
KEYNOTE-942: Neoantigen Therapy Plus Pembrolizumab in Resected Melanoma
Kidney Transplant Recipients: Immunotherapy Strategy for Cutaneous Squamous Cell Carcinoma
AI-Powered Medical Device to Detect Common Skin Cancers Granted FDA Clearance
Use of Cemiplimab-rwlc After Hedgehog Inhibitor Therapy in Locally Advanced Basal Cell Carcinoma
Radiotherapy for Older Adults With Cutaneous Squamous Cell Carcinoma of the Head/Neck
Cutaneous Head and Neck Squamous Cell Carcinoma: Impact of Socioeconomic Factors on Outcomes
Are PD-L1 Expression and Polyomavirus Linked to Survival Among Patients With Merkel Cell Carcinoma?
Surgical Treatment With Three Skin Flaps of Basosquamous Carcinoma: Case Report
Cryosurgery Plus 5-FU vs Monotherapy in Non-Melanoma Skin Cancer: Canadian Study Findings
Squamous Cell Carcinoma of the Eyelid: Multidisciplinary Team Required
Predicting Immunotherapy Responsiveness Based on T-Cell Expression in Patients With Advanced Skin Cancer
Genomic Analysis of Cutaneous Squamous Cell Cancer: What Researchers Have Learned
Mortality and Non-Melanoma Skin Cancer: Surprising Global Trends

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.